Tenaya Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TNYA research report →
About the company
Tenaya Therapeutics, Inc. , a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial.
- CEO
- Faraz Ali
- IPO
- 2021
- Employees
- 70
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $131.10M
- P/E
- -1.67
- P/S
- 582.67
- P/B
- 1.13
- EV/EBITDA
- -0.80
- Div Yield
- 0.00%
- Gross Margin
- 144.89%
- Op Margin
- -38159.11%
- Net Margin
- -36891.11%
- ROE
- -80.56%
- ROIC
- -70.72%
- Revenue
- $0 · 0.00%
- Net Income
- $-90,597,000 · 18.48%
- EPS
- $-0.59 · 54.96%
- Op Income
- $-93,331,000
- FCF YoY
- 24.74%
- 52W High
- $2.35
- 52W Low
- $0.53
- 50D MA
- $0.77
- 200D MA
- $0.98
- Beta
- 2.82
- Avg Volume
- 3.62M
Get TickerSpark's AI analysis on TNYA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 28, 26 | Williams R Sanders | other | 120,000 |
| May 28, 26 | Walsh Jeffrey T. | other | 120,000 |
| May 28, 26 | Stehman-Breen Catherine | other | 120,000 |
| May 28, 26 | Srivastava Deepak | other | 120,000 |
| May 28, 26 | Parschauer Karah Herdman | other | 120,000 |
| May 28, 26 | Lee June | other | 120,000 |
| May 28, 26 | Burroughs Amy L. | other | 120,000 |
| May 18, 26 | Ali Faraz | sell | 3,390 |
| May 18, 26 | Tingley Whittemore | sell | 3,121 |
| May 18, 26 | Higa Tomohiro | sell | 1,485 |
Our TNYA coverage
Recent articles, reports, and earnings notes.
No research on TNYA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TNYA report →Similar companies
Peers in the same neighborhood.